Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles

被引:47
作者
De Jaeghere, F
Allémann, E
Feijen, J
Kissel, T
Doelker, E
Gurny, R [1 ]
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
[2] Univ Twente, Fac Chem Technol, NL-7500 AE Enschede, Netherlands
[3] Univ Marburg, Dept Pharmaceut & Biopharm, Marburg, Germany
关键词
block copolymer; freeze-drying; nanoparticles; poly(ethylene oxide); poly(lactic acid); shelf stability;
D O I
10.1081/PDT-100102031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the formulation and process parameters that determine successful production and long-term stability of freeze-dried poly(lactic acid) (PLA) nanoparticles with "hairy-like" poly(ethylene oxide) (PEG) surfaces were investigated. Nanoparticles with grafted (covalently bound) PEO coatings were produced by the salting-out method from blends of PLA and PLA-PEG diblock or triblock copolymers. PLA nanoparticles with physically adsorbed PEG were also produced The redispersibility of the nanoparticles after freeze-drying under various conditions was assessed. The surface of the nanoparticles was characterized and classified irt terms of ''brush'' and ''loop'' conformations. Upon freeze-drying, it appeared that the presence of PEO at the nanoparticle surface could severely impair the redispersibility of the particles, especially in the PEG-grafted systems. This effect was shown to be related to the amount and molecular weight of PEO in the various formulations. In most cases, particle aggregation was prevented by use of trehalose as lyoprotective agent. Increasing the concentration of particles in the suspension to be freeze-dried was shown to induce much less damage to the nanoparticles, and freezing the suspension at a very low temperature (-196 degreesC) was found to further improve the lyoprotective effect. Most of the lyoprotected nanoparticles remained stable for at least 12 weeks at 4 and -25 degreesC. The production and preservation of freeze-dried PLA-PEO diblock and triblock copolymer nanoparticles is feasible under optimized lyoprotective conditions.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 37 条
[1]   IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE [J].
ALLEMANN, E ;
LEROUX, JC ;
GURNY, R ;
DOELKER, E .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1732-1737
[2]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P13
[3]  
Auvillain M., 1989, S.T.P. pharma, V5, P738
[4]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[5]   Rational design of stable lyophilized protein formulations: Some practical advice [J].
Carpenter, JF ;
Pikal, MJ ;
Chang, BS ;
Randolph, TW .
PHARMACEUTICAL RESEARCH, 1997, 14 (08) :969-975
[6]   Surface-induced denaturation of proteins during freezing and its inhibition by surfactants [J].
Chang, BS ;
Kendrick, BS ;
Carpenter, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (12) :1325-1330
[7]   Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles:: Influence on physical stability and in vitro cell uptake [J].
De Jaeghere, F ;
Allémann, E ;
Leroux, JC ;
Stevels, W ;
Feijen, J ;
Doelker, E ;
Gurny, R .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :859-866
[8]  
deChasteigner S, 1996, DRUG DEVELOP RES, V38, P116, DOI 10.1002/(SICI)1098-2299(199606)38:2&lt
[9]  
116::AID-DDR6&gt
[10]  
3.0.CO